Preconditioning of Tumor, Tumor Microenvironment and the Immune System to Immunotherapy
NCT04225390
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
38
Enrollment
OTHER
Sponsor class
Conditions
Immunotherapy
Interventions
DRUG:
Dacarbazine (DTIC)
Sponsor
University of Erlangen-Nürnberg Medical School
Collaborators
[object Object]
[object Object]
[object Object]